Glaukos

Yahoo Finance • 3 days ago

The Math Shows JHSC Can Go To $47

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 7 days ago

Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Glaukos Corporation stands seventh among them. Glaukos Corporation (NYSE:GKOS), a leader in ophthalmic pharmaceutical and surgical therapi... Full story

Yahoo Finance • 27 days ago

Three Stocks That May Be Undervalued In August 2025

As of late August 2025, the U.S. stock market is experiencing a period of optimism, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. Amid this bullish environment, identifying undervalued stocks c... Full story

Yahoo Finance • 3 months ago

Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif., July 09, 2025--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the t... Full story

Yahoo Finance • 3 months ago

Glaukos receives EU certification for glaucoma surgery devices

ALISO VIEJO, Calif. - Glaukos Corporation (NYSE:GKOS), a $5.67 billion medical device company showing impressive revenue growth of nearly 24% over the last twelve months, has received European Union Medical Device Regulation certification... Full story

Yahoo Finance • 3 months ago

NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

NEW YORK, June 25, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen S... Full story

Yahoo Finance • 3 months ago

Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell

ALISO VIEJO, Calif., June 25, 2025--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal dise... Full story

Yahoo Finance • 5 months ago

Glaukos Corp (GKOS) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ...

Consolidated Net Sales: $106.7 million, up 25% on a reported basis or 26% on a constant currency basis year-over-year. Full Year 2025 Net Sales Guidance: Reaffirmed at $475 million to $485 million. US Glaucoma Franchise Net Sales: $59.1 mi... Full story

Yahoo Finance • 7 months ago

Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz

https://www.tipranks.com/news/the-fly/apple-unveils-iphone-16e-arista-reports-q4-beat-morning-buzz Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. Discover the Best Stocks and Maximize Your P... Full story

Yahoo Finance • 11 months ago

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Phase 3 Confirmatory Trial Met Pre-Specified Primary Efficacy Endpoint and Demonstrated Excellent Tolerability and a Favorable Safety Profile Through 12 Months, Supporting Anticipated New Drug Application (NDA) Submission by End of 2024 D... Full story

Yahoo Finance • last year

Should You Be Bullish on Glaukos Corporation (GKOS)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund declined 2.55% (Institutional Shares) in the quarter compared t... Full story

Yahoo Finance • last year

Glaukos Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Glaukos (NYSE:GKOS) Second Quarter 2024 Results Key Financial Results Revenue: US$95.7m (up 19% from 2Q 2023). Net loss: US$53.9m (loss widened by 64% from 2Q 2023). US$1.06 loss per share (further deteriorated from US$0.68 loss in 2Q 20... Full story

Yahoo Finance • 2 years ago

Insider Sell: Glaukos Corp's President & COO Joseph Gilliam Sells 1,512 Shares

On February 12, 2024, Joseph Gilliam, President & COO of Glaukos Corp, executed a sale of 1,512 shares of the company. The transaction was filed with the SEC and can be found in the official documentation. Glaukos Corp is a medical techno... Full story

Yahoo Finance • 2 years ago

Glaukos Announces Participation in Stifel Healthcare Conference

ALISO VIEJO, Calif., November 07, 2023--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal... Full story

Yahoo Finance • 2 years ago

These 2 Soaring Stocks Finished the Week Strong

The upward momentum in the stock market this week ran out of steam on Friday afternoon, as the Nasdaq Composite (NASDAQINDEX: ^IXIC) and S&P 500 (SNPINDEX: ^GSPC) gave up early gains to close slightly lower. Aehr Test Systems (NASDAQ: AEHR... Full story

Yahoo Finance • 3 years ago

Glaukos Submits New Drug Application to U.S. FDA for iDose TR

ALISO VIEJO, Calif., February 27, 2023--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal... Full story

Yahoo Finance • 3 years ago

15 Small Innovative Companies According to the Media

In this piece, we will take a look at the fifteen small innovative companies according to the media. For more small and innovative companies, head on over to 5 Small Innovative Companies According to the Media. Innovation is the bedrock o... Full story

Yahoo Finance • 3 years ago

15 Largest Ophthalmology Companies in the World

In this article, we will take a look at the 15 largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 5 Largest Ophthalmology Companies in the World. The ophthalmology industry encompa... Full story

Yahoo Finance • 3 years ago

Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium

SAN CLEMENTE, Calif., May 20, 2022--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal dise... Full story

Yahoo Finance • 3 years ago

Glaukos Corporation Announces First Quarter 2022 Financial Results

SAN CLEMENTE, Calif., May 04, 2022--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal dise... Full story